Steven C Katz MD FACS
Hepatobiliary Surgery, Melanoma, Pancreas, Surgical Oncology (Other than Breast)
CMO, TriSalus Life Sciences and Surgical Oncologist at Brown Surgical Associates
Join to View Full Profile
825 Chalkstone AvenuePrior 4Providence, RI 02908
Phone+1 401-456-5312
Fax+1 401-456-6708
Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Katz is a surgical oncologist in Providence, RI and is affiliated with Women & Infants Hospital of Rhode Island and Roger Williams Medical Center. He received his medical degree from NYU School of Medicine and has been in practice 17 years. He also speaks multiple languages, including Hebrew. He specializes in hepatobiliary surgery, melanoma, and soft tissue sarcoma. He runs a translational immunotherapy program, having led five solid tumor CAR-T clinical trials and oversees cGMP cell therapy manufacturing. Dr. Katz recently joined TriSalus Life Sciences as the Chief Medical Officer and continues to practice surgical oncology in selected indications.
Education & Training
Memorial Sloan-Kettering2009
NYU Grossman School of MedicineResidency, Surgery, 2007- NYU Grossman School of MedicineInternship, Surgery, 2000 - 2001
- New York University School of MedicineClass of 2000
Certifications & Licensure
RI State Medical License 2009 - 2026
NY State Medical License 2001 - 2016
OH State Medical License 2008 - 2009
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells Start of enrollment: 2011 Jun 01
- CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases Start of enrollment: 2015 Apr 01
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer Start of enrollment: 2017 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Merkel Cell Carcinoma: Current Treatment Landscape and Emerging Therapeutic Targets.Kelly Pan, A Maria Vromans, Liang Cheng, Jane M Grant-Kels, Steven C Katz
Current Oncology Reports. 2025-06-03 - Pressure-Enabled Drug Delivery Significantly Increases Intra-Arterial Delivery of Embolic Microspheres to Liver Tumors in a Porcine Model.David B Jaroch, Yujia Liu, Alexander Y Kim, Steven C Katz, Bryan F Cox
Journal of Vascular and Interventional Radiology. 2025-03-01 - 1 citationsIntra-arterial Pressure-Enabled Drug Delivery Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model.David B Jaroch, Yujia Liu, Alexander Y Kim, Steven C Katz, Bryan F Cox
Journal of Vascular and Interventional Radiology. 2024-10-01
Journal Articles
- STAT3 Inhibition Induces Bax-Dependent Apoptosis in Liver Tumor Myeloid-Derived Suppressor CellsGeorge Miller, N Joseph Espat, Steven C Katz, Nature
Press Mentions
TriSalus Hires Katz to Run Studies of Ex-Dynavax Cancer DrugSeptember 29th, 2020
High-Pressure Application Breakthrough Aids RWMC’s Immunotherapy AmbitionsDecember 21st, 2018- Rare Disease Day 2024: A Panel Discussion with Dr. Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree SeetharamuMarch 14th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Society of Immunotherapy for CancerMember
- Member
- Society of University SurgeonsMember
- Member
Other Languages
- Hebrew
External Links
- Roger Williams Surgical Oncology http://www.rhodeislandcancer.org
- RWMC Clinical Trialshttp://www.rhodeislandcancer.org/Services/ClinicalTrials/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
